Critical Survey: Arena Pharmaceuticals (ARNA) and Editas Medicine (NASDAQ:EDIT) – The Ledger Gazette
|
Critical Survey: Arena Pharmaceuticals (ARNA) and Editas Medicine (NASDAQ:EDIT)
The Ledger Gazette It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 … Reviewing Editas Medicine (EDIT) & Enanta Pharmaceuticals … Financial Newsletter – Zacks SEC FORM 4 – SEC.gov |
